UVA1 phototherapy: A review of mechanism and therapeutic application

International Journal of Dermatology

Volumn 49, Issue 6, 2010, Pages 623-630

  York, Nathan R ^a   Jacobe, Heidi T ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HALIDE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; UROCANIC ACID;

ACUTE GRAFT VERSUS HOST DISEASE; APOPTOSIS; ATOPIC DERMATITIS; BULLOUS PEMPHIGOID; CYTOKINE PRODUCTION; DYSHIDROSIS; ERYTHEMA; FIBROBLAST; HERPES SIMPLEX; HUMAN; HYPERPIGMENTATION; MASTOCYTOSIS; MELANOMA; MORPHEA; MYCOSIS FUNGOIDES; PHOTOTHERAPY; PITYRIASIS LICHENOIDES; PRURITUS; RADIATION DOSE; REVIEW; SCLERODERMA; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT CONTRAINDICATION; ULTRAVIOLET A RADIATION; IMMUNOLOGY; RADIATION RESPONSE; SKIN DISEASES; T LYMPHOCYTE;

HUMANS; SKIN DISEASES; T-LYMPHOCYTES; ULTRAVIOLET THERAPY;

EID: 77954205745     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2009.04427.x     Document Type: Review

References (53)

1. Plewig G, Hofmann C, Braun-Falco O. A new apparatus for the delivery of high intensity UVA and UVA+UVB irradiation, and some dermatological applications. Br J Dermatol 1978, 98:15-24.
2. Grabbe J, Welker P, Humke S. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996, 107:419-422.
3. Setlow RB, Grist E, Thompson K. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci USA 1993, 90:6666-6670.
4. Young A, Hawk JLM. The molecular and genetic effects of ultraviolet radiation exposure on skin. Photodermatology 1999, 25-42. ed, Hodder, Arnold, London
5. Godar DE. UVA1 radiation triggers two different final apoptotic pathways. J Invest Dermatol 1999, 112:3-12.
6. Guhl S, Hartmann K, Tapkenhinrichs S. Ultraviolet irradiation induces apoptosis in human immature, but not in skin mast cells. J Invest Dermatol 2003, 121:837-844.
7. Baron ED, Stevens SR. Phototherapy for cutaneous T-cell lymphoma. Dermatol Ther 2003, 16:303-310.
8. Skov L, Hansen H, Allen M. Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol 1998, 138:216-220.
9. Krutmann J, Grewe M. Involvement of cytokines, DNA damage, and reactive oxygen intermediates in ultraviolet radiation-induced modulation of intercellular adhesion molecule-1 expression. J Invest Dermatol 1995, 105:67S-70S.
10. Szegedi A, Simics E, Aleksza M. Ultraviolet-A1 phototherapy modulates Th1/Th2 and Tc1/Tc2 balance in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005, 44:925-931.
11. Gruss C, Reed JA, Altmeyer P. Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts. Lancet 1997, 350:1295-1296.
12. Wlaschek M, Heinen G, Poswig A. UVA-induced autocrine stimulation of fibroblast-derived collagenase/MMP-1 by interrelated loops of interleukin-1 and interleukin-6. Photochem Photobiol 1994, 59:550-556.
13. Stege H, Roza L, Vink AA. Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci USA 2000, 97:1790-1795.
14. Morita A. Newly developed phototherapy for atopic dermatitis. AllergolInt 2005, 54:175-180.
15. von Kobyletzki G, Heine O, Stephan H. UVA1 irradiation induces deoxyribonuclease dependent apoptosis in cutaneous T-cell lymphoma in vivo. Photodermatol Photoimmunol Photomed 2000, 16:271-277.
16. Breuckmann F, Stuecker M, Altmeyer P. Modulation of endothelial dysfunction and apoptosis: UVA1-mediated skin improvement in systemic sclerosis. Arch Dermatol Res 2004, 296:235-239.
17. Camacho NR, Sanchez JE, Martin RF. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells. J Am Acad Dermatol 2001, 45:697-699.
18. Kerscher M, Dirschka T, Volkenandt M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995, 346:1166.
19. Kerscher M, Volkenandt M, Gruss C. Low-dose UVA phototherapy for treatment of localized scleroderma. J Am Acad Dermatol 1998, 38:21-26.
20. Kreuter A, Hyun J, Stucker M. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma. J Am Acad Dermatol 2006, 54:440-447.
21. Petering H, Breuer C, Herbst R. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 2004, 50:68-72.
22. Stege H, Berneburg M, Humke S. High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol 1997, 36:938-944.
23. von Kobyletzki G, Uhle A, Pieck C. Acrosclerosis in patients with systemic sclerosis responds to low-dose UV-A1 phototherapy. Arch Dermatol 2000, 136:275-276.
24. Kreuter A, Breuckmann F, Uhle A. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis. J Am Acad Dermatol 2004, 50:740-747.
25. Kreuter A, Gambichler T, Avermaete A. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosis: results of a preliminary study. J Am Acad Dermatol 2002, 46:251-255.
26. Beattie PE, Dawe RS, Ferguson J. UVA1 phototherapy for genital lichen sclerosis. Clin Exp Dermatol 2006, 31:343-347.
27. Ziemer M, Thiele JJ, Gruhn B. Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: improvement of skin lesions, joint mobility, and quality of life. J Am Acad Dermatol 2004, 51:318-319.
28. Grundmann-Kollmann M, Behrens S. Chronic sclerodermic graft-versus-host disease refractory to immunosuppressive treatment responds to UVA1 phototherapy. J Am Acad Dermatol 2000, 42:134-136.
29. Stander H, Schiller M, Schwarz T. UVA1 therapy for sclerodermic graft-versus-host disease of the skin. J Am Acad Dermatol 2002, 46:799-800.
30. Kafi R, Fisher GJ, Quan T. UV-A1 phototherapy improves nephrogenic fibrosing dermopathy. Arch Dermatol 2004, 140:1322-1324.
31. Jekler J, Larko O. Phototherapy for atopic dermatitis with ultraviolet A (UVA), low-dose UVB and combined UVA and UVB: two paired-comparison studies. Photodermatol Photoimmunol Photomed 1991, 8:151-156.
32. Majoie IM, Oldhoff JM, van Weelden H. Narrowband ultraviolet B and medium-dose ultraviolet A1 are equally effective in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol 2009, 60:77-84.
33. Krutmann J, Diepgen TL, Luger TA. High-dose UVA1 therapy for atopic dermatitis: results of a multicenter trial. J Am Acad Dermatol 1998, 38:589-593.
34. Krutmann J, Czech W, Diepgen T. High-dose UVA1 therapy in the treatment of patients with atopic dermatitis. J Am Acad Dermatol 1992, 26:225-230.
35. Dittmar HC, Pflieger D, Schopf E. UVA1 phototherapy. Pilot study of dose finding in acute exacerbated atopic dermatitis. Hautarzt 2001, 52:423-427.
36. Schmidt T, Abeck D, Boeck K. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol 1998, 78:318-319.
37. Stege H, Scho{double acute}f E, Ruzicka T. High-dose UVA1 for urticaria pigmentosa. Lancet 1996, 347:64.
38. Stege H, Budde M, Kürten V. Induction of apoptosis in skin-infiltrating mast cells by high-dose ultraviolet-A-1 (UVA-1) radiation phototherapy in patients with urticaria pigmentosa. J Invest Dermatol 1999, 112:561.
39. Plettenberg H, Stege H, Megahed M. Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 1999, 41:47-50.
40. Pinton PC, Capezzera R, Zane C. Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol 2002, 47:410-414.
41. Zane C, Leali C, Airo P. "High-dose" UVA1 therapy of widespread plaque-type, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001, 44:629-633.
42. McGrath H. Ultraviolet A1 (340-400 nm) irradiation and systemic lupus erythematosus. J Investig Dermatol Symp Proc 1999, 4:79-84.
43. Your Skin and Lupus. 2009, Internet article - Chat Transcript for Dr. Andrew Franks
44. van der Molen RG, Out-Luiting C, Claas FH. Ultraviolet-B radiation induces modulation of antigen presentation of herpes simplex virus by human epidermal cells. Hum Immunol 2001, 62:589-597.
45. Kroft EB, van de Kerkhof PC, Gerritsen MJ. Period of remission after treatment with UVA-1 in sclerodermic skin diseases. J Eur Acad Dermatol Venereol 2008, 22:839-844.
46. Sacher C, Konig C, Scharffetter-Kochanek K. Bullous pemphigoid in a patient treated with UVA-1 phototherapy for disseminated morphea. Dermatology 2001, 202:54-57.
47. Wallenfang K, Stadler R. Association between UVA1 and PUVA bath therapy and development of malignant melanoma. Hautarzt 2001, 52:705-707.
48. Edstrom S, Cvetkovska E, Westin T. Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer. Laryngoscope 2001, 111:124-130.
49. Besaratinia A, Synold TW, Chen HH. DNA lesions induced by UV A1 and B radiation in human cells: comparative analyses in the overall genome and in the p53 tumor suppressor gene. Proc Natl Acad Sci USA 2005, 102:10058-10063.
50. Schnopp C, Rad R, Weidinger A. Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy. Photodermatol Photoimmunol Photomed 2007, 23:81-85.
51. Rana S, Byrne SN, MacDonald LJ. Ultraviolet B suppresses immunity by inhibiting effector and memory T cells. Am J Pathol 2008, 172:993-1004.
52. Yoshizumi M, Nakamura T, Kato M. Release of cytokines/chemokines and cell death in UVB-irradiated human keratinocytes. Cell Biol Int 2008, 32:1405-1411.
53. Piskin G, Tursen U, Sylva-Steenland RM. Clinical improvement in chronic plaque-type psoriasis lesions after narrow-band UVB therapy is accompanied by a decrease in the expression of IFN-gamma inducers - IL-12, IL-18 and IL-23. Exp Dermatol 2004, 13:764-772.